EICU Visicu (MM)

VISICU, Inc. (Nasdaq:EICU), a healthcare information technology and clinical solutions company focused on transforming the delivery of care to the highest acuity patients in the hospital, today announces that it has recently completed a series of steps it believes will lead to a conclusion of the second reexamination�of the VISICU patent. A second reexamination�request�was recently filed in the US Patent and Trademark Office (USPTO) that cited some new references for consideration by the examiner. These references have now been considered and discussed with the reexamination panel and the USPTO is in the process of reaching its decision on the claims of the VISICU patent. Upon reaching its decision,�the USPTO will place the final results of the reexamination on its web site�making it accessible to the public. The web site can be reached at www.uspto.gov; click on "Patents"; then click on "View in PAIR";�then click on "Public PAIR"; the control number for the reexamination is:�90/008,276, and documents can be found under the "Image File Wrapper" tab. According to Frank�T.�Sample, VISICU�s Chairman and CEO, �There has been much�unwarranted hype over the most recent reexamination of our patent. We want the public to know that we�have done�everything that is required to respond to the�second reexamination including: (1) analyzing thoroughly the references that have been cited;�(2)�meeting with the reexamination panel at the USPTO;�and�(3) aggressively preparing a response to the USPTO�(including�an�amendment�to clarify�the claims), which has already been filed, in line with understandings reached with the examiners. In fact, upon completion of this process, these additional references�that have been considered�by the examiners only make the claims of the VISICU patent stronger. We are confident in the reexamination process and its�ultimate�outcome.� About VISICU, Inc. VISICU, Inc. is a healthcare information technology and clinical solutions company transforming the delivery of critical care through its eICU Program. The eICU Program restructures the practice of critical care by using remote monitoring technology to allow systems to centralize scarce critical care trained staff to improve coverage and to allow intervention to prevent or manage crises. For more information, visit www.VISICU.com. VISICU� and eICU� are registered trademarks of VISICU, Inc. All rights reserved. visicu-g Safe Harbor Statement This release contains forward-looking statements that are made pursuant to the provisions of Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements involve a number of risks and uncertainties. Investors are cautioned that statements in this press release that are not strictly historical statements constitute forward-looking statements. It is important to note that the company�s performance, and actual results, financial condition or business could differ materially from those expressed in the forward-looking statements. The words �outlook�, �positions us�, �guidance�, �expects�, �estimates�, �intends�, �plans�, �projects�, �anticipates�, �believes� or the negative of these words, variations thereof or similar expressions are intended to identify such forward-looking statements. Factors that could cause or contribute to such differences include, but are not limited to: market acceptance of the company�s principal product offering and any new product releases, the performance and reliability of our products and services, the company�s ability to attract and retain new customers, renewal rates of the company�s existing customers, financial and budget constraints of hospitals, changes in the company�s or competitors� pricing practices, quarterly operating results may vary, stock price may be volatile, changes in the healthcare industry, the introduction or availability of competing products or services and other competitive factors, changes in the government regulation of our products and services, and the possibility of unfavorable outcomes in regulatory and legal proceedings relating to VISICU's patent that are pending currently or that could be initiated in the future. Additional discussion of these and other factors affecting the company�s business is contained in the company�s periodic filings with the Securities and Exchange Commission. The company undertakes no obligation to update forward-looking statements to reflect changed assumptions the occurrence of unanticipated events or changes in future operating results, financial condition or business over time.